Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001464

Director bought 30,244 shares at an average $5.10 ($154,313)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peyer James Director 2022-01-19 Purchase +10,244 $4.97 $50,913 4,995,876 I: show line 1 in the form
Peyer James Director 2022-01-20 Purchase +20,000 $5.17 $103,400 5,015,876 I: show line 2 in the form
Open-market purchases · 30,244 sh · avg $5.10 · $154,313
Loading xslF345X03/doc1.xml…